Marcos Simoes-Costa in the Department of Molecular Biology and Genetics, and Dan A. Landau with Weill Cornell Medicine have both been awarded $600,000 from the Sontag Foundation to advance their research into brain cancer.
The fourth annual Weill Cornell Medicine Dean’s Symposium on Entrepreneurship and Academic Drug Development drew 125 attendees and served as an urgent reminder of the importance of biomedical innovation.
The “One Health” approach is perfectly suited to tackling the COVID-19 pandemic, the most serious public health crisis in recent history, Cornell researchers said during the university’s COVID-19 Summit, a virtual event held Nov. 4-5.
Researchers and clinicians from Cornell’s Ithaca campus, Weill Cornell Medicine and Cornell Tech will gather for an online COVID-19 Summit, Nov. 4-5, to share their expertise and clinical experience with COVID-19.
Cornell’s network of business incubators and accelerators have developed into a growing and robust entrepreneurial engine nurtured with resources, training and mentorship that help faculty, research staff and graduate students launch marketable ideas and technologies.